Clinical trial of umbilical cord blood NK cell transfusion combined with PD-1 inhibitor for treatment of multiple solid tumors
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Interventions: Group 1:PD-1 inhibitor by Intravenous infusion;Group 2:Intravenous infusion of PD-1 inhibitor (200mg) and UCBNK cells (5×10E6- 5×10E7/kg) the next day Primary outcome(s): objective remission rate (CR, PR, SD, PD) Study Design: Non randomized control
创建时间：
2019-11-15
